financetom
Business
financetom
/
Business
/
US FDA places clinical hold on Tenaya Therapeutics' gene therapy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA places clinical hold on Tenaya Therapeutics' gene therapy
Nov 7, 2025 1:55 PM

Nov 7 (Reuters) - The U.S. Food and Drug Administration

has placed a clinical hold on Tenaya Therapeutics' ( TNYA )

trial of its experimental gene therapy for a type of inherited

heart disease, the company said on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
International Seaways' Q1 Earnings, Revenue Decline
International Seaways' Q1 Earnings, Revenue Decline
May 8, 2024
07:25 AM EDT, 05/08/2024 (MT Newswires) -- International Seaways ( INSW ) reported Q1 earnings Wednesday of $2.92 per diluted share, down from $3.47 a year earlier. Analysts polled by Capital IQ expected $2.28. Revenue for the quarter ended March 31 was $274.4 million, compared with $287.1 million a year earlier. Analysts surveyed by Capital IQ expected $249 million. Price:...
New York Times beats estimates for first-quarter revenue
New York Times beats estimates for first-quarter revenue
May 8, 2024
May 8 (Reuters) - New York Times ( NYT ) beat estimates for first-quarter revenue on Wednesday, as its bundled content offering attracted more subscribers to its website and app ahead of the Paris Summer Olympics and the 2024 U.S. presidential elections. The company reported revenue of $594 million, compared with analysts' estimates of $591.9 million, according to LSEG data....
Shopify forecasts downbeat quarterly revenue growth, shares sink
Shopify forecasts downbeat quarterly revenue growth, shares sink
May 8, 2024
May 8 (Reuters) - Canadian e-commerce platform Shopify ( SHOP ) forecast its slowest quarterly revenue growth in two years against the backdrop of an uncertain economy and tepid consumer spending, sending its U.S. shares slumping 19% in premarket trading. The company said on Wednesday it expects second-quarter revenue to grow at a high-teens percentage rate year on year. That...
Elanco Animal Health Q1 Adjusted Earnings, Revenue Decline; 2024 Earnings Outlook Raised; Shares Rise Pre-Bell
Elanco Animal Health Q1 Adjusted Earnings, Revenue Decline; 2024 Earnings Outlook Raised; Shares Rise Pre-Bell
May 8, 2024
07:25 AM EDT, 05/08/2024 (MT Newswires) -- Elanco Animal Health ( ELAN ) reported Q1 adjusted earnings Wednesday of $0.34 per diluted share, down from $0.45 a year earlier. Analysts polled by Capital IQ expected $0.27 Revenue for the quarter ended March 31 was $1.21 billion, down from $1.26 billion a year earlier. Analysts surveyed by Capital IQ expected $1.17...
Copyright 2023-2026 - www.financetom.com All Rights Reserved